Skip to Content

Change Healthcare Inc Ordinary Shares CHNG Stock Quote

| Rating as of

Morningstar‘s Stock Analysis CHNG

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

DOJ Aims to Block UnitedHealth's Purchase of Change

Julie Utterback, CFA Senior Equity Analyst

Business Strategy and Outlook

| Julie Utterback, CFA |

Change Healthcare offers variations of over a dozen financial and administrative services to support healthcare payers and providers improve administrative efficiency related to submitting and reimbursing medical and dental claims. The company’s revenue is generated by payers and providers with a split of roughly 40% and 60%, respectively. These processing services are focused on administrative accuracy with relatively low fee rates. As a result, there are no material customer concentration issues and no one customer represents more than 4% of revenue. As these various outsourced services address niche needs, there are no direct comparable peers.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CHNG

Company Profile CHNG

Business Description

Change Healthcare is a spin-off of various healthcare processing and consulting services acquired by McKesson over numerous years. Recently, these processing assets were contributed to a joint venture and in June 2019 public shares were issued with McKesson retaining the majority interest. As of the end of the March 2020 quarter, McKesson distributed all its interest in the public processor. Core services consist of insurance (healthcare) claim clearinghouse for healthcare payers in addition to administrative and consulting services to assist healthcare providers improve reimbursement coding, billing, and collections.

Contact
424 Church Street, Suite 1400
Nashville, TN, 37219
T +1 615 932-3000
Industry Health Information Services
Most Recent Earnings Jun 30, 2022
Fiscal Year End Mar 31, 2023
Stock Type Speculative Growth
Employees 14,000